In Vitro Diagnostics Market: Industry Growth, Trends and Forecast 2033 Introduction The In Vitro Diagnostics Market is experiencing steady growth as healthcare systems worldwide emphasize early disease detection and accurate diagnostic testing. In vitro diagnostics (IVD) involve tests performed on biological samples such as blood, urine, or tissue outside the human body to detect...

According to the latest report published by Data Bridge Market Research, the Lab-On-A-Chip Market The Lab-On-A-Chip Market was valued at USD 9.05 billion in 2025 and is projected to reach USD 18.77 billion by 2033, growing at a CAGR of 9.55% from 2026 to 2033 The Lab-On-A-Chip Marketdocument identifies and analyses the emerging trends along with major drivers, challenges and...

According to the latest report published by Data Bridge Market Research, the Multi-Cancer Early Detection Market The global multi-cancer early detection market size was valued at USD 2.65 billion in 2024 and is expected to reach USD 8.13 billion by 2032, at a CAGR of 15.02% during the forecast period With the effectual use of technology, innovative applications and expertise,...

According to the latest report published by Data Bridge Market Research, the NGS Based Molecular Diagnostic Market The global NGS based molecular diagnostic market size was valued at USD 2.34 billion in 2025 and is expected to reach USD 3.82 billion by 2033, at a CAGR of 6.35% during the forecast period With the clear understanding of customer requirement, one method or combination...

Spatial Genomics and Transcriptomics Market: Applications in Oncology, Neuroscience and Immunology (2026–2034) Written By Shubham Senior Healthcare & Biotechnology Market Research Analyst | M2Square ConsultancyExperience: 4+ Years Shubham is a market research analyst specializing in biotechnology, genomics, spatial biology, precision medicine, pharmaceutical analytics, and...

Beyond norovirus and rotavirus, lesser-recognized enteric viruses including astrovirus and sapovirus contribute meaningfully to the viral gastroenteritis disease burden, with the US Viral Gastroenteritis Market reflecting the growing clinical and epidemiological recognition of these pathogens enabled by multiplex molecular diagnostic adoption that previously limited single-pathogen testing...